These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22746545)

  • 1. Polymeric nanospheres as strategy to increase the amount of triclosan retained in the skin: passive diffusion vs. iontophoresis.
    Rodríguez-Cruz IM; Merino V; Merino M; Díez O; Nácher A; Quintanar-Guerrero D
    J Microencapsul; 2013; 30(1):72-80. PubMed ID: 22746545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of triclosan nanoparticles intended to be used for the treatment of acne.
    Domínguez-Delgado CL; Rodríguez-Cruz IM; Escobar-Chávez JJ; Calderón-Lojero IO; Quintanar-Guerrero D; Ganem A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):102-7. PubMed ID: 21295142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of transdermal penetration and iontophoresis of hepatitis B vaccines through rat skin.
    Xu T; Xu YH; Wei MY; Deng LH; Wu CB
    Yao Xue Xue Bao; 2011 Jun; 46(6):713-9. PubMed ID: 21882534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
    Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
    J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoresis-mediated transdermal permeation of peptide dendrimers across human epidermis.
    Mutalik S; Parekh HS; Anissimov YG; Grice JE; Roberts MS
    Skin Pharmacol Physiol; 2013; 26(3):127-38. PubMed ID: 23549205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term iontophoretic and post-iontophoretic transport of model penetrants across excised human epidermis.
    Akomeah FK; Martin GP; Brown MB
    Int J Pharm; 2009 Feb; 367(1-2):162-8. PubMed ID: 18950696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
    Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
    J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
    Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
    Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres.
    Quintanar-Guerrero D; Tamayo-Esquivel D; Ganem-Quintanar A; Allémann E; Doelker E
    Eur J Pharm Sci; 2005 Oct; 26(2):211-8. PubMed ID: 16046105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
    Yin J; Noda Y; Yotsuyanagi T
    Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive and iontophoretic permeation of glipizide.
    Jain A; Ghosh B; Rajgor N; Desai BG
    Eur J Pharm Biopharm; 2008 Aug; 69(3):958-63. PubMed ID: 18291633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoadhesive, triclosan-loaded polymer microspheres for application to the oral cavity: preparation and controlled release characteristics.
    Kockisch S; Rees GD; Tsibouklis J; Smart JD
    Eur J Pharm Biopharm; 2005 Jan; 59(1):207-16. PubMed ID: 15567319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocopheryl succinate-based lipid nanospheres for paclitaxel delivery: preparation, characters, and in vitro release kinetics.
    Shi K; Jiang Y; Zhang M; Wang Y; Cui F
    Drug Deliv; 2010 Jan; 17(1):1-10. PubMed ID: 19941405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
    Kalaria DR; Patel P; Patravale V; Kalia YN
    Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy.
    Gelfuso GM; Gratieri T; Souza JG; Thomazine JA; Lopez RF
    Eur J Pharm Biopharm; 2011 Feb; 77(2):249-56. PubMed ID: 21118720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.
    Dubey S; Perozzo R; Scapozza L; Kalia YN
    Mol Pharm; 2011 Aug; 8(4):1322-31. PubMed ID: 21696184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S; Kalia YN
    J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.